Shee, K., Wells, J. D., Ung, M., Hampsch, R. A., Traphagen, N. A., Yang, W., . . . Miller, T. W. (2019). A transcriptionally-definable subgroup of triple-negative breast and ovarian cancer samples shows sensitivity to HSP90 inhibition. Clin Cancer Res.
Citação norma ChicagoShee, Kevin, et al. "A Transcriptionally-definable Subgroup of Triple-negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition." Clin Cancer Res 2019.
MLA引文Shee, Kevin, et al. "A Transcriptionally-definable Subgroup of Triple-negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition." Clin Cancer Res 2019.
警告:這些引文格式不一定是100%准確.